Francisco Jimenez, MD
Obstetrics · South Miami, FLNPI 1629028253
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $825 and has fallen 51.0% since, to $404 in 2025.
Across 143 payments — averaging $23.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$792
- AbbVie$612
- Mayne Pharma Commercial LLC$470
- Boston Scientific$191
- Hologic Sales And Service, LLC$177
- Evofem Biosciences, Inc.$123
- plus $974 from 22 others
What the payments were for
- Food & beverage$3,05892%
- Education$2818%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 21 | $792 |
| AbbVie(2 entities) | 34 | $612 |
| Mayne Pharma Commercial LLC | 17 | $470 |
| Boston Scientific | 4 | $191 |
| Hologic Sales And Service, LLC | 9 | $177 |
| Evofem Biosciences, Inc. | 6 | $123 |
| Vertical Pharmaceuticals, LLC | 8 | $114 |
| Therapeuticsmd, Inc. | 5 | $103 |
| Coopersurgical, Inc. | 5 | $86 |
| Exeltis, USA Inc. | 4 | $83 |
| Biogen | 3 | $79 |
| United Therapeutics Corporation | 3 | $74 |
| Avion Pharmaceuticals | 5 | $62 |
| Shield Therapeutics Inc | 2 | $58 |
| Myovant Sciences Inc. | 2 | $42 |
| Pfizer | 2 | $37 |
| Coloplast | 1 | $30 |
| Medicem Inc. | 2 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Duchesnay USA Incorporated | 1 | $22 |
| Agile Therapeutics, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Bayer | 1 | $17 |
| Millicent US Inc | 1 | $15 |
| Organon | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$250
How this compares
$3,339 in reported general payments places this provider in the 80th percentile of 78 obstetrics providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $1,789 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $273 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in South Miami
- Robert FeldmanSouth Miami$10K
- Ileana PerezSouth Miami$4K
- Wilkens MondesirGreenacres$16K
- Phan NguyenNaples$14K
- Nasim KhanSebring$11K
- Ivonne ReynoldsMargate$11K
- Isidro MartinezMiami$10K
- Michele LemayBradenton$10K
- Kyle GarnerSarasota$9K
- Robert BassPlantation$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.